Selected Publications

Harry-Hernandez S, Thiboutot J, Wahidi MM, Giovacchini CX, De Cardenas J, Meldrum C, Los JG, Illei PB, Shojaee S, Eissenberg T, DiBardino D, Giannini HM, Maldonado F, Roller L, Yarmus LB, Kapp CM. : Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort. J Bronchology Interv Pulmonol. Page: epub ahead of print, Aug 2022.

Giannini HM, Meyer NJ. : Genetics of Acute Respiratory Distress Syndrome: Pathways to Precision. Crit Care Clin. 37(4): 817-834, Oct 2021.

Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A, Geßner R, Giannini HM, Gonzalez J, Greib S, Gündisch M, Hsu AR, Kuo A, Manohar M, Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro J, Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James JA, Kim PS, Meyer NJ, Nadeau KC, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Luning Prak ET, Utz PJ. : New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 12(1): 5417 epub, Sep 2021.

Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, Greenplate AR, Hwee MA, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman AR, Ittner CAG, Kugler EM, Baxter AE, Oniyide O, Agyekum RS, Dunn TG, Jones TK, Giannini HM, Weirick ME, McAllister CM, Babady NE, Kumar A, Widman AJ, DeWolf S, Boutemine SR, Roberts C, Budzik KR, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles JR, Oldridge DA, Wu JE, Alanio C, Adamski S, Garfall AL, Vella LA, Kerr SJ, Cohen JV, Oyer RA, Massa R, Maillard IP, Maxwell KN, Reilly JP, Maslak PG, Vonderheide RH, Wolchok JD, Hensley SE, Wherry EJ, Meyer NJ, DeMichele AM, Vardhana SA, Mamtani R, Huang AC.: CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 27(7): 1280-1289, Jul 2021.

Vella LA, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, Alanio C, Pampena MB, Wu JE, Chen Z, Huang YJ, Anderson EM, Gouma S, McNerney KO, Chase J, Burudpakdee C, Lee JH, Apostolidis SA, Huang AC, Mathew D, Kuthuru O, Goodwin EC, Weirick ME, Bolton MJ, Arevalo CP, Ramos A, Jasen CJ, Conrey PE, Sayed S, Giannini HM, D'Andrea K, Meyer NJ, Behrens EM, Bassiri H, Hensley SE, Henrickson SE, Teachey DT, Betts MR, Wherry EJ.: Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol. 6(57): 1-15, Mar 2021.

Giannini HM, Ginestra JC, Chivers C.: A Machine Learning Algorithm to Predict Severe Sepsis and Septic Shock: Development, Implementation, and Impact on Clinical Practice. Crit Care Med. 47(11): 1485-1492, Mar 2019.

Ginestra JC, Giannini HM, Schweickert WD: Clinician Perception of a Machine Learning-Based Early Warning System Designed to Predict Severe Sepsis and Septic Shock. Crit Care Med. 47(11): 1477-1484, Mar 2019.

Murphy T, Melville H, Fradkin E, Bistany G, Branigan G, Olsen K, Comstock CR, Hanby H, Garbade E, DiBenedetto AJ: Knockdown of epigenetic transcriptional co-regulator Brd2a disrupts apoptosis and proper formation of hindbrain and midbrain-hindbrain boundary (MHB) region in zebrafish. Mechanisms of Development 146(6): 10-30, Sep 2017.

Sangodkar J, Perl A, Tohme R, Kiselar J, Kastrinsky DB, Zaware N, Izadmehr S, Mazhar S, Wiredja DD, O’Connor CM, Hoon, D, Dhawan, NS, Schlatzer, D, Yao, S, Leonard, D, Borczuk, AC, Gokulrangan, G, Wang, L, Svenson, E, Farrington, CC, Yuan, E, Avelar, RA, Stachnik, A, Smith, B, Gidwani, V, Giannini, HM, McQuaid, D, McClinch, K, Wang, Z, Levine, AC, Sears, RC, Chen, EY, Duan, Q, Datt, M, Haider, S, Ma’ayan, A, DiFeo, A, Sharma, N, Galsky, MD, Brautigan, DL, Ioannou, YA, Xu, W, Chance, MR, Ohlmeyer, M, Narla, G: Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth. Journal of Clinical Invest 127(4): 2081-2090, Jun 2017.

Kastrinsky DB, Sangodkar J, Zaware N, McClinch K, Farrington C, Giannini HM, Izadmehr S, Dhawan NS, Narla G, Ohlmeyer M: Reengineered tricyclic anti-cancer agents. Bioorg Med Chem 23; 6528–6534 23(1): 6528-6534, Feb 2015.